Drug Type Small molecule drug |
Synonyms CP-394531 |
Target |
Action antagonists |
Mechanism GR antagonists(Glucocorticoid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 1 | Preclinical | United States | 08 Jul 2002 | |
| Glaucoma | Discovery | United States | - | |
| Neurodegenerative Diseases | Discovery | United States | - | |
| Obesity | Discovery | United States | - | |
| Pituitary ACTH Hypersecretion | Discovery | United States | - |





